HR 10239 · 118th Congress · Health

End Drug Shortages Act

Introduced 2024-11-21· Sponsored by Rep. Spanberger, Abigail Davis [D-VA-7]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the House Committee on Energy and Commerce.(2024-11-21)

Plain Language Summary

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 10239 Introduced in House (IH)] <DOC> 118th CONGRESS 2d Session H. R. 10239 To amend the Federal Food, Drug, and Cosmetic Act to expand drug shortage notification practices to include surges in demand for a drug, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES November 21, 2024 Ms. Spanberger (for herself and Mr. Smith of Nebraska) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To amend the Federal Food, Drug, and Cosmetic Act to expand drug shortage notification practices to include surges in demand for a drug, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``End Drug Shortages Act''. SEC. 2. DRUG SHORTAGE NOTIFICATION PRACTICES. Section 506C of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 356c) is amended-- (1) in the section heading, by inser…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (2)

1 Democrat1 Republican